Home » Reports » Broker Ratings » AstraZeneca plc 16.8% Potential Upside Indicated by Deutsche Bank

AstraZeneca plc 16.8% Potential Upside Indicated by Deutsche Bank

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Deutsche Bank. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set their target price at 6800 GBX on its stock. This is indicating the analyst believes there is a potential upside of 16.8% from today’s opening price of 5820 GBX. Over the last 30 and 90 trading days the company share price has decreased 300 points and increased 128 points respectively. The 1 year high stock price is 6540 GBX while the year low share price is currently 5110 GBX.

AstraZeneca plc has a 50 day moving average of 6,173.81 GBX and a 200 day moving average of 5,998.42. There are currently 1,311,759,192 shares in issue with the average daily volume traded being 3,049,485. Market capitalisation for LON:AZN is £77,393,792,328 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn